Deutsche Bank’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-221,300
| Closed | -$3.31M | – | 5495 |
|
|
2016
Q2 | $3.31M | Sell |
221,300
-10,298
| -4% | -$132K | ﹤0.01% | 2051 |
|
|
2016
Q1 | $2.82M | Buy |
231,598
+47,461
| +26% | +$666K | ﹤0.01% | 2137 |
|
|
2015
Q4 | $2.93M | Buy |
184,137
+117,870
| +178% | +$1.86M | ﹤0.01% | 2164 |
|
|
2015
Q3 | $1.01M | Sell |
66,267
-47,178
| -42% | -$1.02M | ﹤0.01% | 2935 |
|
|
2015
Q2 | $2.76M | Buy |
113,445
+60,788
| +115% | +$1.46M | ﹤0.01% | 2206 |
|
|
2015
Q1 | $1.22M | Sell |
52,657
-34,427
| -40% | -$911K | ﹤0.01% | 2765 |
|
|
2014
Q4 | $2.19M | Buy |
87,084
+10,160
| +13% | +$298K | ﹤0.01% | 2611 |
|
|
2014
Q3 | $2.39M | Buy |
76,924
+11,388
| +17% | +$308K | ﹤0.01% | 2393 |
|
|
2014
Q2 | $1.69M | Buy |
65,536
+43,681
| +200% | +$970K | ﹤0.01% | 2549 |
|
|
2014
Q1 | $509K | Buy |
21,855
+9,903
| +83% | +$217K | ﹤0.01% | 3326 |
|
|
2013
Q4 | $302K | Sell |
11,952
-14,425
| -55% | -$326K | ﹤0.01% | 3434 |
|
|
2013
Q3 | $537K | Buy |
26,377
+13,269
| +101% | +$295K | ﹤0.01% | 3436 |
|
|
2013
Q2 | $274K | Buy |
+13,108
| New | +$234K | ﹤0.01% | 3603 |
|
Deutsche Bank's SGNT Position: Q3 2016 in Review
Deutsche Bank sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 221,300 shares — an estimated $3.31M sold.
Deutsche Bank first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $3.31M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.
- Deutsche Bank reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
- Deutsche Bank sold 221,300 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $3.31M.
- Deutsche Bank first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
- Deutsche Bank's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.31M in Q2 2016.
- 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.
Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.